表紙
市場調查報告書

生物資訊學的全球市場:成長,趨勢,及預測(2019年∼2024年)

Bioinformatics Market - Growth, Trends, and Forecast (2019 - 2024)

出版商 Mordor Intelligence LLP 商品編碼 390860
出版日期 內容資訊 英文 123 Pages
商品交期: 2-3個工作天內
價格
生物資訊學的全球市場:成長,趨勢,及預測(2019年∼2024年) Bioinformatics Market - Growth, Trends, and Forecast (2019 - 2024)
出版日期: 2019年11月01日內容資訊: 英文 123 Pages
簡介

本報告提供全球生物資訊學市場的相關調查,市場機會和趨勢,成長及阻礙因素,各產品&服務、用途、地區的市場分析,競爭情形,主要企業的簡介等資訊。

目錄

第1章 簡介

  • 調查成果
  • 調查的前提條件
  • 調查範圍

第2章 調查方法

第3章 摘要整理

第4章 市場動態

  • 市場概況
  • 市場成長要素
    • 核酸及蛋白質定序需求的增加
    • 來自政府及民間組織的配合措施的增加
    • 蛋白質體學及基因學的成長的加速
    • 分子生物學及藥物研發相關研究的增加
  • 市場阻礙因素
    • 明確定義的標準及資料整合用的一般數據格式的缺乏
    • 資料複雜的疑慮及缺乏用戶友善的工具
  • 波特的五力分析
    • 新加入廠商的威脅
    • 買主/消費者談判力
    • 供應商談判力
    • 替代產品的威脅
    • 產業內的競爭

第5章 市場區隔

  • 各產品、服務
    • 知識管理工具
    • 生物資訊學平台
    • 生物資訊學服務
  • 各用途
    • 微生物基因
    • 基因工程學
    • 藥物研發
    • 個人化醫療
    • 體學
    • 其他
  • 各地區
    • 北美
    • 歐洲
    • 亞太地區
    • 中東、非洲
    • 南美

第6章 競爭情形

  • 企業簡介
    • Illumina Inc.
    • Life Technologies (Thermo Fischer Scientific)
    • Qiagen NV
    • Agilent Technologies
    • PerkinElmer
    • ABM
    • Accelrys Inc.
    • Geneva Bioinformatics SA
    • Ontoforce
    • Data4Cure
    • Life Map Sciences (Biotime)

第7章 市場機會及今後趨勢

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 50460

Market Overview

The propelling factors for the growth of the global bioinformatics market include the increasing demand for nucleic acid and protein sequencing, increasing initiatives from government and private organizations, accelerating growth of proteomics and genomics, and increasing research on molecular biology and drug discovery. Owing to the aforementioned factors, the global bioinformatics market is expected to experience a boost during the forecast period.

Bioinformatics is gaining importance, as large amounts of data generated through techniques, like nucleic acid and protein sequencing, require data management and interpretation for future researches and medical purposes. Hence, increasing demand is expected to drive the bioinformatics market during the forecast period.

The demand for differentially expressed genes, computational epigenetics, meta-analysis of microarray data, gene network, systems biology requirements, and gene-associating studies, among others, has had a major impact on the growth of the global bioinformatics market.

Thus, technical advancements, along with the advent of the NGS technology, have helped in the development of bioinformatics tools for analyzing a great amount of data. This has contributed to the growth of the global bioinformatics market.

There is also little research that has been done in the field of bioinformatics to expedite decision-making in healthcare. Within clinical or medical informatics, there is a rich history of research on systems designed to help care providers and patients (healthcare consumers) and make optimal decisions surrounding diagnosis and management.

Scope of the Report

As per the scope of the report, bioinformatics is the application of computational technology to gather, store, analyze, and integrate biological data. This data is used to procure information and is applied to gene-based drug discovery and development, protein structure studies, and the determination of the therapeutic efficacy of drugs.

Key Market Trends

Personalized Medicine is the Segment under Application that is Expected to Grow the Fastest During the Forecast Period

Bioinformatics is an essential component in basic research and in the development of new concepts for diagnosis and therapy, as well as in clinical practice, in which these concepts are applied to treat patients. Some of the major drivers that help in the increasing demand for bioinformatics are, growing applications of bioinformatics in drug discovery and development and growing bioinformatics support in the development of personalized medicines and clinical diagnostics.

Asia-Pacific Holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period

A large number of healthcare investments in the Asia-Pacific region are expected to drive the bioinformatics market. Furthermore, the high adoption of IoT technologies in this sector is expected to impact market growth in the region positively. Key countries, including China and India, are expected to propel the bioinformatics market in this region mainly.

Competitive Landscape

Many pharmaceutical companies are minimizing drug discovery budgets, as they are shifting their focus from outsourcing of the software to developing in-house tools, thus allowing them to customize their required applications to meet their needs and increasing workflow efficiency. The major global players in the bioinformatics market include Illumina, Thermo Fisher Scientific, and Agilent Technologies, among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client's requirements
  • 3 months of analyst support

TABLE OF CONTENTs

1. INTRODUCTION

  • 1.1. Study Deliverables
  • 1.2. Study Assumptions
  • 1.3. Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1. Market Overview
  • 4.2. Market Drivers
    • 4.2.1. Increasing Demand for Nucleic Acid and Protein Sequencing
    • 4.2.2. Increasing Initiatives from Governments and Private Organizations
    • 4.2.3. Accelerating Growth of Proteomics and Genomics
    • 4.2.4. Increasing Research on Molecular Biology and Drug Discovery
  • 4.3. Market Restraints
    • 4.3.1. Lack of Well-defined Standards and Common Data Formats for Integration of Data
    • 4.3.2. Data Complexity Concerns and Lack of User-friendly Tools
  • 4.4. Porter's Five Forces Analysis
    • 4.4.1. Threat of New Entrants
    • 4.4.2. Bargaining Power of Buyers/Consumers
    • 4.4.3. Bargaining Power of Suppliers
    • 4.4.4. Threat of Substitute Products
    • 4.4.5. Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1. By Product and Services
    • 5.1.1. Knowledge Management Tools
    • 5.1.2. Bioinformatics Platform
      • 5.1.2.1. Interventional/Surgical Simulators
      • 5.1.2.2. Sequence Analysis Platform
      • 5.1.2.3. Sequence Alignment Platform
      • 5.1.2.4. Sequence Manipulation Platform
      • 5.1.2.5. Structural and Functional Analysis Platform
      • 5.1.2.6. Other Bioinformatics Platforms
    • 5.1.3. Bioinformatics Services
      • 5.1.3.1. Sequencing Services
      • 5.1.3.2. Database and Management Services
      • 5.1.3.3. Data Analysis
      • 5.1.3.4. Other Bioinformatics Services
  • 5.2. By Application
    • 5.2.1. Microbial Genome
    • 5.2.2. Gene Engineering
    • 5.2.3. Drug Development
    • 5.2.4. Personalized Medicine
    • 5.2.5. Omics
    • 5.2.6. Other Applications
  • 5.3. Geography
    • 5.3.1. North America
      • 5.3.1.1. United States
      • 5.3.1.2. Canada
      • 5.3.1.3. Mexico
    • 5.3.2. Europe
      • 5.3.2.1. Germany
      • 5.3.2.2. United Kingdom
      • 5.3.2.3. France
      • 5.3.2.4. Italy
      • 5.3.2.5. Spain
      • 5.3.2.6. Rest of Europe
    • 5.3.3. Asia-Pacific
      • 5.3.3.1. China
      • 5.3.3.2. Japan
      • 5.3.3.3. India
      • 5.3.3.4. Australia
      • 5.3.3.5. South Korea
      • 5.3.3.6. Rest of Asia-Pacific
    • 5.3.4. Middle East & Africa
      • 5.3.4.1. GCC
      • 5.3.4.2. South Africa
      • 5.3.4.3. Rest of Middle East & Africa
    • 5.3.5. South America
      • 5.3.5.1. Brazil
      • 5.3.5.2. Argentina
      • 5.3.5.3. Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1. Company Profiles
    • 6.1.1. Illumina Inc.
    • 6.1.2. Life Technologies (Thermo Fischer Scientific)
    • 6.1.3. Qiagen NV
    • 6.1.4. Agilent Technologies
    • 6.1.5. PerkinElmer
    • 6.1.6. ABM
    • 6.1.7. Accelrys Inc.
    • 6.1.8. Geneva Bioinformatics SA
    • 6.1.9. Ontoforce
    • 6.1.10. Data4Cure
    • 6.1.11. Life Map Sciences (Biotime)

7. MARKET OPPORTUNITIES AND FUTURE TRENDS